{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T23:08:10Z","timestamp":1785020890383,"version":"3.55.0"},"reference-count":35,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Mens Health"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>This study explores aspects that men consider when deciding whether to participate in a prostate cancer screening program and how the information in the invitation letter contributed to their decision. Semi-structured interviews were conducted with 50- to 62-year-old men invited by letter to a population-based prostate cancer screening program. Data from transcribed interviews were analyzed using qualitative content analysis using manifest and indicative approaches. Eighteen men were interviewed, 10 whom chose to be tested, and 8 who declined screening. The information in the invitation letter was not decisive for whether men chose to be tested or not. The aspects that the men valued in their personal decision to participate or refrain from screening were categorized as (a) the expectation that authorities should take responsibility and provide guidance; (b) fear, which was described as both a driving force and a barrier; (c) reliance upon intuition combined with seeking social and emotional support; (d) the perception of one\u2019s own risk of being affected. Men who relied on risk assessment mentioned difficulties in evaluating the information about the potential disadvantages of screening. Our findings suggest that the intention of informed decision-making for prostate cancer screening is difficult to fully realize. Further research is needed to understand how the individual decision-making process is influenced by factors such as assessment of personal risk, perception of advantages and disadvantages, and cultural background, and to optimize the information to the invited men.<\/jats:p>","DOI":"10.1177\/15579883251344563","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:45:34Z","timestamp":1750668334000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Prostate Cancer Screening Decisions: Which Aspects Do Men Value Most? An Interview Study With Men Invited to a Population-Based Program"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-8095","authenticated-orcid":false,"given":"Linda","family":"Svensson","sequence":"first","affiliation":[{"name":"Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden"},{"name":"Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-9445","authenticated-orcid":false,"given":"Ola","family":"Bratt","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden"},{"name":"Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Hugosson","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden"},{"name":"Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Stinesen","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden"},{"name":"Department of Social Work, University of Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","unstructured":"Alterbeck M. J\u00e4rbur E. Thimansson E. Wallstr\u00f6m J. Bengtsson J. Bj\u00f6rk-Eriksson T. Bjartell A. Bratt O. Jiborn T. Arnsrud Godtman R. (2022). Designing and implementing a population-based organised prostate cancer testing programme. European Urology Focus 8 1568\u20131574. https:\/\/doi.org\/10.1016\/j.euf.2022.06.008","DOI":"10.1016\/j.euf.2022.06.008"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","unstructured":"Auvinen A. Rannikko A. Taari K. Kujala P. Mirtti T. Kentt\u00e4mies A. Rinta-Kiikka I. Lehtim\u00e4ki T. Oksala N. Pettersson K. Tammela T. L. (2017). A randomized trial of early detection of clinically significant prostate cancer (ProScreen): Study design and rationale. European Journal of Epidemiology 32(6) 521\u2013527. https:\/\/doi.org\/10.1007\/s10654-017-0292-5","DOI":"10.1007\/s10654-017-0292-5"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","unstructured":"Bell N. Gorber S. C. Shane A. Joffres M. Singh H. Dickinson J. Shaw E. Dunfield L. Tonelli M. (2014). Recommendations on screening for prostate cancer with the prostate-specific antigen test. Canadian Medical Association Journal 186(16) 1225\u20131234. https:\/\/doi.org\/10.1503\/cmaj.140703.","DOI":"10.1503\/cmaj.140703"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","unstructured":"Bratt O. Auvinen A. Arnsrud Godtman R. Hellstr\u00f6m M. Hugosson J. Lilja H. Wallstr\u00f6m J. Roobol M. J. (2023) Screening for prostate cancer: Evidence ongoing trials policies and knowledge gaps. BMJ Oncology 2 e000039. https:\/\/doi.org\/10.1136\/bmjonc-2023-000039","DOI":"10.1136\/bmjonc-2023-000039"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.501.13.4"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","unstructured":"Consedine N. S. Morgenstern A. H. Kudadjie-Gyamfi E. Magai C. Neugut A. I. (2006). Prostate cancer screening behavior in men from seven ethnic groups: The fear factor. Cancer Epidemiol Biomarkers & Prevention 15(2) 228\u2013237. https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0019","DOI":"10.1158\/1055-9965.EPI-05-0019"},{"issue":"1","key":"e_1_3_2_8_1","first-page":"26","article-title":"PSA cancer screening: a case for shared decision-making","volume":"69","author":"Dasarathy J.","year":"2020","unstructured":"Dasarathy J., Rajesh R. (2020). PSA cancer screening: a case for shared decision-making. The Journal of Family Practice, 69(1), 26\u201328, 30\u201332, 46.","journal-title":"The Journal of Family Practice"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","unstructured":"Douma L. N. Uiters E. Verweij M. F. Timmermans D. R. M. (2020) Autonomous and informed decision-making: The case of colorectal cancer screening. PLoS One 15(5) e0233308. https:\/\/doi.org\/10.1371\/journal.pone.0233308","DOI":"10.1371\/journal.pone.0233308"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","unstructured":"Eldh CA. Ekman I. Ehnfors M. (2008). Considering patient non-participation in health care. Health Expectations 11 263\u2013271. https:\/\/doi.org\/10.1111\/j.1369-7625.2008.00488","DOI":"10.1111\/j.1369-7625.2008.00488.x"},{"key":"e_1_3_2_11_1","article-title":"Council recommendation of 9 December 2022 on strengthening prevention through early detection: A new EU approach on cancer screening replacing Council Recommendation 2003\/878\/EC","author":"European Union Council","year":"2022","unstructured":"European Union Council. (2022). Council recommendation of 9 December 2022 on strengthening prevention through early detection: A new EU approach on cancer screening replacing Council Recommendation 2003\/878\/EC. Official Journal of the European Union, C 473\/1.","journal-title":"Official Journal of the European Union"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","unstructured":"Ferrante J. M. Shaw E. K. Scott J. G. (2011). Factors influencing men\u2019s decisions regarding prostate cancer screening: A qualitative study. Journal of Community Health 36(5) 839\u2013844. https:\/\/doi.org\/10.1007\/s10900-011-9383-5","DOI":"10.1007\/s10900-011-9383-5"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","unstructured":"Graneheim U. H. Lindgren B.-M. Lundman B. (2017) Methodological challenges in qualitative content analysis: A discussion paper. Nurse Education Today 56 29\u201334. https:\/\/doi.org\/10.1016\/j.nedt.2017.06.002","DOI":"10.1016\/j.nedt.2017.06.002"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"Graneheim U. H. Lundman B. (2004). Qualitative content analysis in nursing research: Concepts procedures and measures to achieve trustworthiness. Nurse Education Today 24(2) 105\u2013112. https:\/\/doi.org\/10.1016\/j.nedt.2003.10.001","DOI":"10.1016\/j.nedt.2003.10.001"},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","unstructured":"Hugosson J. M\u00e5nsson M. Wallstr\u00f6m J. Axcrona U. Carlsson S. Egevad L. Geterud K. Khatami A. Kohestani K. Pihl C.-G. Socratous A. Stranne J. Arnsrud Godtman R. Hellstr\u00f6m M. (2022). Prostate cancer screening with PSA and MRI followed by targeted biopsy only. The New England Journal of Medicine 387 2126\u20132137. https:\/\/doi.org\/10.1056\/NEJMoa2209454","DOI":"10.1056\/NEJMoa2209454"},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","unstructured":"Hugosson J. Roobol M. J. M\u00e5nsson M. Tammela T. L. J. Zappa M. Nelen V. Kwiatkowski M. Lujan M. Carlsson S. V. Talala K. M. Lilja H. Denis L. J. Recker F. Paez A. Puliti D. Villers A. Rebillard X. Kilpel\u00e4inen T. P. Stenman U. H. Auvinen A. (2019). A 16-yr follow-up of the European randomized study of screening for prostate cancer. European Urology 76(1) 43\u201351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.009","DOI":"10.1016\/j.eururo.2019.02.009"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","unstructured":"Jauernik C. P. Rahbek O. J. Ploug T. Siersma V. Brodersen J. B. (2023). The impact of influences in a medical screening programme invitation: a randomized controlled trial. The European Journal of Public Health 33(3) 509\u2013514. https:\/\/doi.org\/10.1093\/eurpub\/ckad067","DOI":"10.1093\/eurpub\/ckad067"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","unstructured":"Jepson R. G. Hewison J. Thompson A. G. H. Weller D. (2005). How should we measure informed choice? The case of cancer screening. Journal of Medical Ethics 31 192\u2013196. https:\/\/doi.org\/10.1136\/jme.2003.005793","DOI":"10.1136\/jme.2003.005793"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","unstructured":"Kohestani K. M\u00e5nsson M. Arnsrud Godtman R. Stranne J. Wallstr\u00f6m J. Carlsson S. Hellstr\u00f6m M. Hugpsson J. (2021) The G\u00d6TEBORG prostate cancer screening 2 trial: a prospective randomised population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate. Scandinavian Journal of Urology 55 116\u2013124. https:\/\/doi.org\/10.1080\/21681805.2021.1881612","DOI":"10.1080\/21681805.2021.1881612"},{"key":"e_1_3_2_20_1","doi-asserted-by":"crossref","unstructured":"Li J. Ding H. Richards T. B. Martin I. Kobrin S. Marcus P. M. (2018). Prostate-specific antigen testing initiation and shared decision-making: Findings from the 2000 and 2015 National Health Interview Surveys. Journal of the American Board of Family Medicine 31(4) 658\u2013662. https:\/\/doi.org\/10.3122\/jabfm.2018.04.170448","DOI":"10.3122\/jabfm.2018.04.170448"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","unstructured":"Lin K. Lipsitz R. Miller T. Janakiraman S. (2008). Benefits and harms of prostate-specific antigen screening for prostate cancer: An evidence update for the US Preventive Services Task Force. Annals of Internal Medicine 149(3) 192\u2013199. https:\/\/doi.org\/10.7326\/0003-4819-149-3-200808050-00009","DOI":"10.7326\/0003-4819-149-3-200808050-00009"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","unstructured":"Lindgren B. M. Lundman B. Graneheim U. H. (2020). Abstraction and interpretation during the qualitative content analysis process. International Journal of Nursing Studies 108 103632. https:\/\/doi.org\/10.1016\/j.ijnurstu.2020.103632","DOI":"10.1016\/j.ijnurstu.2020.103632"},{"key":"e_1_3_2_23_1","doi-asserted-by":"crossref","unstructured":"Malterud K. Siersma V. D. Guassora A. D.(2016). Sample size in qualitative interview studies: Guided by information power. Qualitative Health Research 26(13) 1753\u20131760. https:\/\/doi.org\/10.1177\/1049732315617444","DOI":"10.1177\/1049732315617444"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","unstructured":"Marteau T. M. Dormandy E. (2001). Facilitating informed choice in prenatal testing: How well are we doing? American Journal of Medical Genetics 106 185\u2013190. https:\/\/doi.org\/10.1002\/ajmg.10006","DOI":"10.1002\/ajmg.10006"},{"key":"e_1_3_2_25_1","doi-asserted-by":"crossref","unstructured":"McCormick M. E. Haile Z. T. (2023). The impact of receipt of information on prostate-specific antigen testing on screening with the prostate-specific antigen Test. Journal Cancer Education 38(4) 1313\u20131321. https:\/\/doi.org\/10.1007\/s13187-023-02264-1","DOI":"10.1007\/s13187-023-02264-1"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","unstructured":"McGrath C. Palmgren P. J. Liljedahl M. (2019). Twelve tips for conducting qualitative research interviews. Medical Teacher 41 1002\u20131006. https:\/\/doi.org\/10.1080\/0142159X.2018.1497149","DOI":"10.1080\/0142159X.2018.1497149"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1037\/1089-2680.2.2.175"},{"key":"e_1_3_2_28_1","doi-asserted-by":"crossref","unstructured":"Rai T. Clements A. Bukach C. Shine B. Austoker J. Watson E. (2007). What influences men\u2019s decision to have a prostate-specific antigen test? A qualitative study. Family Practice 24(4) 365\u2013371. https:\/\/doi.org\/10.1093\/fampra\/cmm033","DOI":"10.1093\/fampra\/cmm033"},{"key":"e_1_3_2_29_1","doi-asserted-by":"crossref","unstructured":"Shaw E. K. Scott J. G. Ferrante J. M. (2023). The influence of family ties on men\u2019s prostate cancer screening biopsy and treatment decisions. American Journal of Men\u2019s Health 7(6) 461\u2013471. https:\/\/doi.org\/10.1177\/1557988313480226","DOI":"10.1177\/1557988313480226"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","unstructured":"Smith R. A. Andrews K. S. Brooks D. Fedewa S. A. Manassaram-Baptiste D. Saslow D. Brawley W. O. Wender C. R. (2018). Cancer screening in the United States 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA:A Cancer Journal for Clinicians 68(4) 297\u2013316. https:\/\/doi.org\/10.3322\/caac.21446","DOI":"10.3322\/caac.21446"},{"key":"e_1_3_2_31_1","doi-asserted-by":"crossref","unstructured":"Stenfors T. Kajamaa A. Bennett D. (2020). How to assess the quality of qualitative research. Clinical Teacher 17(6) 596\u2013599. https:\/\/doi.org\/10.1111\/tct.13242","DOI":"10.1111\/tct.13242"},{"key":"e_1_3_2_32_1","doi-asserted-by":"crossref","unstructured":"Svendsen R. P. Jarbol D. E. Larsen P. V. St\u00f8vring H. Hansen B. L. Soendergaard J. (2013). Associations between health care seeking and socioeconomic and demographic determinants among people reporting alarm symptoms of cancer: a population-based cross-sectional study. Family Practice 30(6) 655\u2013665. https:\/\/doi.org\/10.1093\/fampra\/cmt036","DOI":"10.1093\/fampra\/cmt036"},{"key":"e_1_3_2_33_1","doi-asserted-by":"crossref","unstructured":"Svensson L. Bratt K. S. Jiborn T. B\u00f6rjedahl A. C. Bratt O. (2023). Men\u2019s perception of being invited for prostate cancer testing and the information about its pros and cons: A survey from two population-based testing programmes. European Urology Open Science 52 66\u201371. https:\/\/doi.org\/10.1016\/j.euros.2023.03.012","DOI":"10.1016\/j.euros.2023.03.012"},{"key":"e_1_3_2_34_1","unstructured":"US Preventive Services Task Force. (2018). Published final recommendation summary. Prostate cancer: screening. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/prostate-cancer-screening"},{"key":"e_1_3_2_35_1","doi-asserted-by":"crossref","unstructured":"Van den Berg M Timmermans DRM ten Kate LP van Vugt JMG. (2006) Informed decision making in the context of prenatal screening. Patient Education and Counseling. 2006; 63(1-2):110-117. https:\/\/doi.org\/10.1016\/j.pec.2005.09.007.","DOI":"10.1016\/j.pec.2005.09.007"},{"key":"e_1_3_2_36_1","doi-asserted-by":"crossref","unstructured":"Vrinten C. Waller J. Von Wagner C. Wardle J. (2015). Cancer fear: Facilitator and deterrent to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers & Prevention 24(2) 400\u2013405. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0967","DOI":"10.1158\/1055-9965.EPI-14-0967"}],"container-title":["American Journal of Men's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15579883251344563","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15579883251344563","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15579883251344563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:28:14Z","timestamp":1777505294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15579883251344563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1177\/15579883251344563"],"URL":"https:\/\/doi.org\/10.1177\/15579883251344563","relation":{},"ISSN":["1557-9883","1557-9891"],"issn-type":[{"value":"1557-9883","type":"print"},{"value":"1557-9891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"article-number":"15579883251344563"}}